Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by Sarb99on Jan 17, 2021 12:38am
290 Views
Post# 32314656

RE:RE:Medivolve portfolio company Sataty IPS added a location.

RE:RE:Medivolve portfolio company Sataty IPS added a location.

If this is up to me, I will renegotiate private placement at a higher price with a changed situation. Medivolve is in a much better position compared to a few weeks back. Biden wants to offer free testing for all by investing $50 billion in buying testing results. Medivolve having 50-200 testing sites by the end of next month can capitalize on this. 

 

Especially if Medivolve sees Cannacord keeping the MEDV price down just because of waiting for the private placement to be completed. I say Cancel this private placement and release revenue numbers from collection sites, RESAAS and Columbia. Now, Medivolve should be able to arrange private placement at much higher prices. 

 

I think Doug Sommerville said they were slow installing new testing sites because of difficulty in hiring people because of holidays. It seems that problem is solved as now as a lot of those posted jobs are gone. Earlier this week, there were over 300 jobs available, now only 214 https://www.indeed.com/jobs?q=company%3A%28Collection+Sites+LLC%29&l=&radius=25 So over 100 jobs got filled this week. 

 

They can even try loans based on insurance billing money coming in. If they don't want to renegotiate, then complete it now and let's get it going. Enough waiting now is the time to help people with testing and shareholders with generating revenue. 


maidenmist wrote: How about PP on 26th? Any comment?


<< Previous
Bullboard Posts
Next >>